Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases

Mehta M 1 , Paudel KR 2 , Panth N 2 , Xenaki D 3 , Macloughlin R 4 , Oliver BG 5 Show all authors , Lobenberg R 6 , Hansbro PM 2 , Chellappan DK 7 , Dua K 1

Affiliations 

  • 1 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia
  • 2 Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia
  • 3 Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW 2037, Australia
  • 4 Aerogen, IDA Business Park, Dangan, Galway H91 HE94, Ireland
  • 5 School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW 2007, Australia
  • 6 University of Alberta, Faculty of Pharmacy & Pharmaceutical Sciences, Edmonton, AB, T6G 2N8, Canada
  • 7 Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur 57000, Malaysia
Nanomedicine (Lond), 2021 03;16(6):437-439.
PMID: 33599533 DOI: 10.2217/nnm-2021-0016

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications